ArticleClinical parkinsonism & related disorders2025

Bioequivalence of Foslevodopa/Foscarbidopa continuous subcutaneous infusion to arm, thigh, or flank versus abdomen in healthy and advanced Parkinson's disease individuals.

Yi Rang Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.